What is the current Global Pulmonary Drugs Market size?

The Global Pulmonary Drugs Market is projected to register a CAGR of 5.40% during the forecast period (2024-2029) Read More

Who are the key players in Global Pulmonary Drugs Market?

Boehringer Ingelheim, Merck & Co., AstraZeneca PLC, GlaxoSmithKline PLC and Grifols, S.A. are the major companies operating in the Global Pulmonary Drugs Market. Read More

Which is the fastest growing region in Global Pulmonary Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Pulmonary Drugs Market?

In 2024, the North America accounts for the largest market share in Global Pulmonary Drugs Market. Read More

What years does this Global Pulmonary Drugs Market cover?

The report covers the Global Pulmonary Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Pulmonary Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Pulmonary Drugs Market - Share & Size

Pulmonary Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Breathing Disorders Treatment Market Growth and the market is segmented by Drug Class (Beta-2 Agonists, Anticholinergic Agents, Oral and Inhaled Corticosteroids, Anti-leukotrienes, Antihistamines, Monoclonal Antibodies, Combination Drugs, and others), Indication (Asthma, COPD (Chronic Obstructive Pulmonary Disease), Allergic Rhinitis, Pulmonary Arterial Hypertension, Cystic Fibrosis, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Pulmonary Drugs Industry Overview

The global pulmonary drugs market is highly competitive and consists of a number of major players. Companies like AstraZeneca, Boehringer Ingelheim, AstraZeneca PLC, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Grifols, S.A., Merck & Co., Inc., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., and Teva Pharmaceutical Industries Ltd. hold the substantial market share in the Pulmonary Drugs market.